Nutriband Inc.

About Nutriband Inc.

Nutriband Inc. focuses on innovative transdermal drug delivery systems and patient-focused pharmaceutical products, with a core mission to improve patient outcomes by addressing the global opioid epidemic. Through its subsidiaries, including 4P Therapeutics, it develops technologies like AVERSA to enhance the safety of opioid-based transdermal medications such as fentanyl, aiming to save lives with FDA-approved solutions.

Products & Services

AVERSA Technology:An abuse-deterrent fentanyl patch designed to revolutionize safety standards for opioid-based transdermal medications.

Transdermal Products for Injected Compounds:Development of transdermal delivery systems for drugs typically delivered by injection, including proteins, peptides, macromolecules, and biologics, to improve safety, efficacy, and therapeutic outcomes.

Sports Recovery Products (Active Intelligence):Specialized products focused on sports recovery.

Contract Manufacturing (Pocono Pharmaceutical):Services in coated materials, consulting, formulations, and manufacturing.

Clinical R&D (4P Therapeutics):Research and development of novel drug delivery technologies and therapeutics from preclinical testing to early-stage clinical development (Phase I/II).

Specialties

Transdermal Drug Delivery Abuse-Deterrent Technology Opioid Safety Solutions Clinical Research and Development Contract Manufacturing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 5306000 MR: - FA: $5,306,000 FAN: 5306000	D: 2025-09-03 FD: 2025-09-03	-
2	RT: Private Placement T: - FT: Private Placement	A: 8400000 MR: - FA: 8.4M FAN: 8400000	D: 2024-04-19 FD: 2024-04-19	-
3	RT: Debt T: - FT: Debt	A: 5000000 MR: - FA: 5 Million USD FAN: 5000000	D: 2023-07-14 FD: 2023-07-14	-
4	RT: Line of Credit T: - FT: Line of Credit	A: 2000000 MR: - FA: $2,000,000 FAN: 2000000	D: 2023-03-28 FD: 2023-03-28	-

Warrant Exercise Latest

2025-09-03

$5.3M

Private Placement 2024-04-19

$8.4M

Debt 2023-07-14

$5.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Srinivas Nalamachu

Member of Advisory Board

T

Thomas Cooney

Member of Advisory Board

G

Gareth Sheridan

CEO

M

Mark Hamilton

Member Board of Directors

S

Stefani Mancas

Member Board of Directors

S

Serguei Melnik

Founder, Acting CEO, President

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Nutriband Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised